Systems and methods for treatment of prostatic tissue

US9526555B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9526555-B2
Application numberUS-201213595914-A
CountryUS
Kind codeB2
Filing dateAug 27, 2012
Priority dateNov 6, 2008
Publication dateDec 27, 2016
Grant dateDec 27, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.

First claim

Opening claim text (preview).

What is claimed is: 1. A prostate ablation system, comprising: a vapor generator; and a vapor delivery probe operatively coupled to the vapor generator and adapted to be inserted transurethrally into a prostate adjacent to a prostatic urethra of a patient, the vapor delivery probe adapted to deliver condensable vapor from the vapor generator into the prostate to deliver between 100 and 10,000 Joules to the prostate to ablate the prostate without ablating the prostatic urethra. 2. The system of claim 1 wherein the vapor generator is disposed within the vapor delivery probe. 3. The system of claim 2 wherein the vapor generator is disposed within a handle of the vapor delivery probe. 4. The system of claim 1 wherein the vapor delivery probe further comprises a vapor needle configured to be advanced through the prostatic urethra into the prostate. 5. The system of claim 4 wherein the vapor needle comprises a plurality of vapor ports configured to deliver condensable vapor to the prostate. 6. The system of claim 4 wherein the vapor needle is coupled to an actuation mechanism configured to advance the vapor needle through the prostatic urethra into the prostate. 7. The system of claim 6 wherein the actuation mechanism is configured to advance the vapor needle into an apex of the prostate. 8. The system of claim 7 wherein the actuation mechanism is configured to advance the vapor needle at least 15 mm into the prostate. 9. The system of claim 6 wherein the actuation mechanism is manually controlled. 10. The system of claim 9 wherein the manually controlled actuation mechanism comprises a spring-loaded mechanism. 11. The system of claim 10 further comprising a lever on a handle of the vapor delivery probe configured to actuate the spring-loaded mechanism. 12. The system of claim 6 wherein the actuation mechanism is computer controlled. 13. The system of claim 1 wherein the condensable vapor undergoes a phase change after it is delivered to the prostate. 14. The system of claim 1 wherein the condensable vapor delivers between 100 W and 400 W to the prostate. 15. The system of claim 1 wherein the condensable vapor delivers between 250 cal/gm and 450 cal/gm to the prostate. 16. The system of claim 1 wherein the condensable vapor delivers between 20 W and 100 W to the prostate. 17. The system of claim 1 wherein the condensable vapor delivers between 100 cal/gm and 600 cal/gm to the prostate.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9526555B2 cover?
A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.
Who is the assignee on this patent?
Hoey Michael, Shadduck John H, Nxthera Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).